Study the efficacy of phalatrikadi kwath in the management of non alcoholic fatty liver disease grade 1 and grade 2
Phase 2
- Conditions
- Health Condition 1: K759- Inflammatory liver disease, unspecified
- Registration Number
- CTRI/2023/05/053029
- Lead Sponsor
- TAPUBRATA BARUAH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Pain in the right upper quadrant/epigastric region,
2.Nausea
3.Vomiting
4.Loss of appetite
5.Burning sensation in abdomen
6.USG(whole abdomen) showing fatty infiltration of liver
7.Biochemical test,LFT findings
Exclusion Criteria
1.Viral hepatitis
2.Autoimmune hepatitis
3.Wilson disease
4.Alfa 1 antitrypsin deficiency
5.Haemochromatosis
6.Alcoholic fatty liver
7.Pregnancy and lactation
8.Severe cardiac problem
9.Cancer patients
10.Psychiatric disorder
11.Stomach ulcer
12.Surgical interventions,if any
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The symptoms of fatty liver such as loss of appetite ,nausea,vomiting will subsideTimepoint: 30 days to 6 months
- Secondary Outcome Measures
Name Time Method The biochemical markers i.e. LFT,lipId profile will go to normal limitsTimepoint: 30 days to 6 months